- Poster presentation
- Open Access
Early vs. persistent microvascular obstruction following primary PCI- two pathologies or one? A cardiovascular magnetic resonance study
© Kidambi et al.; licensee BioMed Central Ltd. 2014
- Published: 16 January 2014
- Acute Myocardial Infarction
- Cardiovascular Magnetic Resonance
- Late Gadolinium Enhancement
- Contrast Administration
- Microvascular Obstruction
20-40% of reperfused ST-elevation acute myocardial infarction (STEMI) features microvascular obstruction (MO), which confers adverse prognosis. Different CMR sequences are commonly used to detect MO: first pass perfusion (FPP), early gadolinium enhancement (EGE), and late gadolinium enhancement (LGE). FPP and EGE are more sensitive than LGE for the detection of MO. However, only MO by LGE has been shown to confer prognostic information. It is unclear whether these three methods detect separate pathologies, or whether differences in MO appearances merely reflect contrast distribution over time. We aimed to determine how appearances between these methods are related.
60 patients underwent CMR at 3.0T within 3 days following reperfused first STEMI. MO imaging was performed at identically-planned basal, mid-ventricular and apical short-axis slices. FPP imaging was performed during administration of 0.1 mmol/kg Gd-DTPA contrast. 4 minutes after contrast administration, EGE imaging was performed, followed by LGE imaging at both 10 minutes and at 20 minutes. MO was identified as a dark core within infarcted myocardium. We compared area and transmural extent of MO for each method on a per-patient and a per-slice basis.
The reduction in visible size of MO is proportional to extent of MO and time from contrast administration. Contrast diffusion into the MO zone may be responsible for reduction in MO size between the methods rather than differing clinical or imaging factors. Smaller areas of MO on EGE and FPP become undetectable on LGE, while larger areas are detectable but smaller on LGE. MO by LGE therefore identifies more extensive MO than FPP or EGE, possibly explaining its higher predictive value.
JPG and SP receive a research grant from Philips Healthcare. SP is funded by British Heart Foundation fellowship (FS/10/62/28409).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.